Clearer questions. More informed care.Our commercial disclosure

Care & access

Online GLP-1 providers: a practical comparison

Compare the clinical relationship and complete purchase across selected providers, with sources and a disclosed CoreAge Rx placement.

Document research · No independent medical review claimed
On this page
  1. How to use this comparison
  2. 01. CoreAge Rx — commercial first position
  3. 02. Mochi Health
  4. 03. Ro
  5. 04. Henry Meds
  6. 05. Lavender Sky Health
  7. 06. TrimRx
  8. 07. Ivím Health
  9. 08. MEDVi
  10. Make the comparison specific to you
  11. Sources & research notes

This guide looks at the clinical relationship and complete purchase. The aim is to help you ask a better next question, whether you are checking a first prescription offer or thinking about moving to another service.

The services below have different care and payment models. We describe their own published terms and link to fuller files, so an appealing price can be read alongside the work, obligations, and uncertainties attached to it.

How to use this comparison

Decide whether you need scheduled visits, messaging, pharmacy coordination, or local care before comparing the advertisements.

CoreAge Rx has a commercial first position in this guide. We may be compensated through its links. The sequence is not an independently calculated medical ranking, and inclusion does not mean every service supplies every feature discussed here.

Use the documents for the actual treatment, location, and payment agreement. A service may be useful to compare even when its approach differs: a consultation-only pathway, an inclusive package, and a care membership should not be assumed to buy the same thing.

  • Name the exact care service.
  • Request the complete payment schedule.
  • Check the product, pharmacy, and exit terms.
Source notes1

01. CoreAge Rx — commercial first position

This is the featured commercial partner. The placement should not be interpreted as proof of superior outcomes, lower total cost, or the best clinical choice for a particular person.

CoreAge Rx describes assessment online followed by dispensing when a clinician issues a prescription. It is Panda Bear’s commercial partner; that arrangement determines its featured position, not an assessment of treatment quality.

Its offer advertises semaglutide from $99 and tirzepatide from $149. The billing help uses $447 paid for three months to illustrate a $149 monthly equivalent. No additional membership fee is advertised, but the selected product and supply period still control the invoice.

Will my receipt show one payment or recurring charges, and which pharmacy will be on the label?

Open our CoreAge Rx review for the terms, evidence limits, and published contact routes.

Source notes23456

02. Mochi Health

Mochi’s membership provides the care arrangement; its medication bill is additional. An August 2026 explanation describes medication prices that vary by tier, so older flat-price descriptions need checking.

The standard membership is $79 monthly, with a $39 introductory month advertised. Published medication ranges are $60–$99 for semaglutide and $90–$199 for tirzepatide. These ranges are not instructions to choose a dose according to price.

What is the recurring total at the tier my clinician prescribes, and on which dates are the two charges taken?

Open our Mochi Health review for the terms, evidence limits, and published contact routes.

Source notes789

03. Ro

Ro’s Body pathway describes branded medication access and help with insurance. Membership, prescribing review, and the pharmacy benefit remain distinct parts of the arrangement.

The membership offer shows $39 initially, then $149 monthly. An annual payment can produce a $74 monthly equivalent. None of those membership amounts includes the medicine itself; insurance or the cash-pay pharmacy price must be added.

If insurance refuses the medicine, what will I already have paid for care and what options remain?

Open our Ro review for the terms, evidence limits, and published contact routes.

Source notes1011

04. Henry Meds

Henry Meds offers several weight-management arrangements with remote assessment. Its FAQ describes care, supplies, and prescribed medicine within packages, including different formulations and treatment durations.

GLP-1 programs are advertised from $179 monthly. The selected route and agreement matter: an oral compound, an injection, and a longer purchase should each be quoted explicitly rather than grouped under that starting number.

What would remain owed if treatment stopped halfway through the agreement, and which exception rules could apply?

Open our Henry Meds review for the terms, evidence limits, and published contact routes.

Source notes12

05. Lavender Sky Health

Lavender Sky Health publishes several pharmacy options and charges for consultations. Availability still depends on the prescription and location; a listed pharmacy is a candidate to check, not an assigned dispenser.

A new-patient consultation is listed at $65 and an established-patient consultation at $40. Medication is priced separately. Compare the actual quantity, intended duration, and pharmacy preparation in addition to those clinical fees.

Which pharmacy package fits the prescription, and when would another paid consultation be required?

Open our Lavender Sky Health review for the terms, evidence limits, and published contact routes.

Source notes1314151617

06. TrimRx

TrimRx describes a prescribing service that works with pharmacies outside the platform. For identity checks, keep the website, medical practice, and dispensing business on separate lines of your notes.

The accessible comparison material advertises tirzepatide at $349 monthly. Earlier terms contained different first-order and follow-up figures. Because the terms could not be refreshed on September 22, we do not treat that older schedule as a current personalized quote.

Can you send the agreement that governs this offer, with the initial payment, repeat payment, and refund deadline?

Open our TrimRx review for the terms, evidence limits, and published contact routes.

Source notes18192021

07. Ivím Health

Ivím promotes continuing support alongside medication plans. Program-outcome material on its website is observational evidence about a program, not a randomized trial of every compounded preparation it may arrange.

The captured offer shows six-month drug equivalents of $75 for semaglutide and $133 for tirzepatide. Membership is separately advertised at $75 monthly with the first month free. Ask how both commitments align before using either drug figure as the total.

How much of the medication term requires paid membership, and how would each charge change if treatment ended?

Open our Ivím Health review for the terms, evidence limits, and published contact routes.

Source notes222324

08. MEDVi

An FDA warning letter dated February 20, 2026 addresses MEDVi’s marketing of unapproved GLP-1 drugs. It is relevant evidence about the claims specified there. The existence of a website, support team, or clinical intake does not settle those concerns.

The reviewed documents do not establish a dependable single price for all MEDVi weight-management plans. QUAD pricing belongs to another treatment category and cannot be used to budget for a GLP-1 prescription.

What product would I receive, and where can I read the current response to the specific FDA concerns?

Open our MEDVi review for the terms, evidence limits, and published contact routes.

Source notes252627

Make the comparison specific to you

After reading the options, select the questions you still need answered. Ask each provider for the same time period, named prescription, and clinical access. Record unclear items as unresolved instead of choosing the lowest advertised number.

If the medicine, route, or treatment goal differs, discuss that difference with the clinician before treating it as an ordinary shopping substitution. The cost worksheet can help compare payments while keeping the medical decision separate.

Source notes28

Trace the information

Sources & research notes

Provider documents describe the provider’s own offer. Official medical references explain context; they do not endorse this publication or its featured partner.

  1. FDA: concerns with unapproved GLP-1 drugs Regulatory / public agency · Checked September 22, 2026
  2. CoreAge Rx: official treatment overview Provider-published information · Checked September 22, 2026
  3. CoreAge Rx: current sale offer Provider-published information · Checked September 22, 2026
  4. CoreAge Rx: plan billing explained Provider-published information · Checked September 22, 2026
  5. CoreAge Rx: contact and professional-entity disclosures Provider-published information · Checked September 22, 2026
  6. CoreAge Rx: purchasing process Provider-published information · Checked September 22, 2026
  7. Online Medical Weight Loss Program | Mochi Health Provider-published information · Checked September 22, 2026
  8. Mochi: August 2026 dose-based pricing Provider-published information · Checked September 22, 2026
  9. Contact us | Mochi Health Provider-published information · Checked September 22, 2026
  10. Weight Loss - Ro Body Membership | Ro Provider-published information · Checked September 22, 2026
  11. Ro - Telehealth for ED, Hair loss, Skincare, Fertility and More Provider-published information · Checked September 22, 2026
  12. GLP-1 Weight Loss Treatment | Henry Provider-published information · Checked September 22, 2026
  13. Home - Lavender Sky Health Provider-published information · Checked September 22, 2026
  14. Services Pricing - Lavender Sky Health Provider-published information · Checked September 22, 2026
  15. Treatment Plan Pricing - Lavender Sky Health Provider-published information · Checked September 22, 2026
  16. Terms and Policies - Lavender Sky Health Provider-published information · Checked September 22, 2026
  17. Contact Us | Lavender Sky Health - Lavender Sky Health Provider-published information · Checked September 22, 2026
  18. TrimRx: official site and medical disclosures Provider-published information · Checked September 21, 2026The latest direct refresh was unreadable. The earlier source date is retained; obtain the current document before relying on commercial terms. September 22 refresh returned no readable page. The linked document was captured September 21; request a current copy before relying on its terms.
  19. TrimRx: current terms, pricing, and refunds Provider-published information · Checked September 21, 2026The latest direct refresh was unreadable. The earlier source date is retained; obtain the current document before relying on commercial terms. September 22 refresh returned no readable page. The linked document was captured September 21; request a current copy before relying on its terms.
  20. TrimRx: shipping policy and support Provider-published information · Checked September 21, 2026The latest direct refresh was unreadable. The earlier source date is retained; obtain the current document before relying on commercial terms. September 22 refresh returned no readable page. The linked document was captured September 21; request a current copy before relying on its terms.
  21. TrimRx: provider-written tirzepatide comparison Provider-published information · Checked September 22, 2026
  22. Ivím Health – Individualized Health & Wellness Programs Provider-published information · Checked September 22, 2026
  23. Terms and Conditions – Ivím Health Provider-published information · Checked September 22, 2026
  24. Ivím Health: refill process and support contacts Provider-published information · Checked September 22, 2026
  25. MEDVi: provider, pharmacy, and contact disclosures Provider-published information · Checked September 22, 2026
  26. FDA: MEDVi warning letter, February 20, 2026 Regulatory / public agency · Checked September 22, 2026
  27. MEDVi QUAD: product and ingredient page Provider-published information · Checked September 22, 2026
  28. FDA: risks of compounded drugs Regulatory / public agency · Checked September 22, 2026

Use this guide to prepare questions, not to choose or change a prescription without clinical advice. Research method · Commercial disclosure

Your next useful question

Keep the conversation going.